We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+11.54%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$2.67B
AUM Growth
-$255M
Cap. Flow
-$501M
Cap. Flow %
-18.76%
Top 10 Hldgs %
64.43%
Holding
673
New
208
Increased
118
Reduced
162
Closed
161

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$268M
2
AMZN icon
Amazon
AMZN
+$226M
3
BSX icon
Boston Scientific
BSX
+$55.2M
4
PYPL icon
PayPal
PYPL
+$42.9M
5
ADBE icon
Adobe
ADBE
+$33.3M

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$241M
2
MU icon
Micron Technology
MU
+$171M
3
INTC icon
Intel
INTC
+$163M
4
MSFT icon
Microsoft
MSFT
+$121M
5
AAPL icon
Apple
AAPL
+$112M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 32.16%
2 Technology 19.26%
3 Healthcare 6%
4 Financials 5.81%
5 Energy 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNL icon
501
Global Net Lease
GNL
$1.95B
$139K 0.01%
16,476
-75,051
-82% -$630K
TASK icon
502
TaskUs
TASK
$651M
$136K 0.01%
+10,519
New +$149K
RGNX icon
503
Regenxbio
RGNX
$688M
$122K ﹤0.01%
+11,637
New +$142K
METC icon
504
Ramaco Resources Class A
METC
$645M
$122K ﹤0.01%
+10,783
New +$129K
NFBK
505
DELISTED
Northfield Bancorp
NFBK
$120K ﹤0.01%
10,331
-4,387
-30% -$50.3K
CCCC icon
506
C4 Therapeutics
CCCC
$400M
$120K ﹤0.01%
21,002
ABSI icon
507
Absci
ABSI
$1.53B
$94.5K ﹤0.01%
+24,725
New +$98.3K
EHAB
508
DELISTED
Enhabit
EHAB
$85.5K ﹤0.01%
+10,822
New +$94.1K
SIGA icon
509
SIGA Technologies
SIGA
$210M
$82.7K ﹤0.01%
+12,246
New +$107K
OPTU
510
Optimum Communications Inc
OPTU
$306M
$67.3K ﹤0.01%
+27,378
New +$52.9K
ADV icon
511
Advantage Solutions
ADV
$383M
$56.8K ﹤0.01%
+662
New +$61K
CLOV icon
512
Clover Health Investments
CLOV
$2.41B
$33.3K ﹤0.01%
+11,804
New +$27K
AAOI icon
513
Applied Optoelectronics
AAOI
$11.2B
-411,054
Closed -$3.41M
ABNB icon
514
Airbnb
ABNB
$111B
-40,000
Closed -$6.07M
ADP icon
515
Automatic Data Processing
ADP
$109B
-2,376
Closed -$567K
ADTN icon
516
Adtran
ADTN
$622M
-22,531
Closed -$119K
AES icon
517
AES
AES
$10.5B
-10,085
Closed -$177K
AHCO icon
518
AdaptHealth
AHCO
$696M
-38,334
Closed -$383K
ALEC icon
519
Alector
ALEC
$189M
-20,282
Closed -$92.1K
ALGN icon
520
Align Technology
ALGN
$12.5B
-2,948
Closed -$712K
AN icon
521
AutoNation
AN
$6.88B
-6,230
Closed -$993K
APA icon
522
APA Corp
APA
$14.4B
-9,400
Closed -$277K
APH icon
523
Amphenol
APH
$207B
-63,980
Closed -$4.31M
ARDX icon
524
Ardelyx
ARDX
$997M
-34,971
Closed -$259K
ARW icon
525
Arrow Electronics
ARW
$10.3B
-15,323
Closed -$1.85M

Similar funds

Caxton Associates (New York)'s Q3 2024 Portfolio in Review

As of Q3 2024, Caxton Associates (New York) held 673 positions worth $2.67B, down 8.7% from $2.93B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Caxton Associates (New York) withdrew a net $501M in Q3 2024, closing 161 positions and reducing 162 holdings. Its most notable exit was Micron Technology, an estimated $171M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 32% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Caxton Associates (New York) opened a new position in Boston Scientific worth $58.7M.

  • Caxton Associates (New York)'s largest Q3 2024 buy was Boston Scientific: 700,000 shares worth $58.7M.
  • Caxton Associates (New York) added most to Tesla in Q3 2024, an estimated $268M increase.
  • Caxton Associates (New York)'s biggest Q3 2024 reduction was Citigroup, cutting an estimated $241M.
  • Caxton Associates (New York) fully exited Micron Technology in Q3 2024, selling an estimated $171M.
  • Caxton Associates (New York)'s ten largest holdings make up 64% of its $2.67B portfolio in Q3 2024.
  • Caxton Associates (New York) opened 208 new positions and closed 161 in Q3 2024.
  • Caxton Associates (New York)'s portfolio value fell 8.7% quarter-over-quarter to $2.67B.

Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.